# kTMP in Chronic Stroke

Study · id `cardio:ct-nct07277595` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07277595](<https://clinicaltrials.gov/study/NCT07277595>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07277595

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07277595. Randomized; double masking; primary purpose treatment. Start 2026-07-01 (anticipated); primary completion 2030-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07277595, source copy `cardio:ctgov-nct07277595-2026-05-06`, retrieved 2026-10-26)
- Planned start: 2026-07-01 (anticipated) (ClinicalTrials.gov record NCT07277595, source copy `cardio:ctgov-nct07277595-2026-05-06`, retrieved 2026-10-26)
- Primary completion: 2030-08-01 (anticipated) (ClinicalTrials.gov record NCT07277595, source copy `cardio:ctgov-nct07277595-2026-05-06`, retrieved 2026-10-26)
- Completion: 2030-08-01 (anticipated) (ClinicalTrials.gov record NCT07277595, source copy `cardio:ctgov-nct07277595-2026-05-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07277595, source copy `cardio:ctgov-nct07277595-2026-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07277595-2026-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: kTMP in Chronic Stroke
- Acronym: KULMINATE
- Condition: Stroke
- Condition: Chronic Stroke Patients
- Condition: Arm Weakness as a Consequence of Stroke
- Intervention (Device): kTMP sham stimulation 9 weeks + active stimulation 9 weeks
- Intervention (Device): kTMP 18 weeks
- Lead sponsor: University of California, San Francisco
- Lead sponsor class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of California, San Francisco (`cardio:org-university-of-california-san-francisco`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)

## Provenance

Content hash: 461d19ba44aaf6f98c8f77a2d55d42632d628b74105bcc072905c601cc1f7c9f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
